Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Donaldson (DCI) Displays Solid Prospects, Headwinds Persist

Published 11/12/2019, 09:03 PM
Updated 07/09/2023, 06:31 AM

On Nov 13, we issued an updated research report on Donaldson Company, Inc. (NYSE:DCI) .

In the past three months, this Zacks Rank #3 (Hold) stock has rallied 16.1% compared with the industry’s increase of 10.5%.


Existing Scenario

Donaldson has been gaining from strong demand for its razor-to-sell razor-blade products and dust collection replacement parts, particularly in China. Product launches, new program wins and growing e-commerce business are likely to drive its revenues in the quarters ahead.

Also, the company is poised to boost its competency on the back of its ongoing capital expenditure and innovation investments. In this regard, its capital expenditure totaled $38 million in fourth-quarter fiscal 2019 (ended July 2019), up 66.7% year over year. These investments were made toward capacity expansion projects.

Further, the BOFA International acquisition (closed on Oct 22, 2018) has been strengthening the company's Industrial Products segment. For fiscal 2020 (ending July 2020), Donaldson expects the BOFA buyout to add $9-$10 million to sales growth at the industrial filtration solutions business.

However, the company seems concerned about the tough operating environment. For fiscal 2020, the company anticipates global equipment production to be down in the low to mid-single-digit range. For fiscal 2020, it predicts sales to be in the range of 2% decline to 4% increase compared with 4% growth recorded in fiscal 2019 (ended July 2019).

In addition, escalating costs have been a major cause of concern. For instance, Donaldson’s cost of sales jumped 5.5% in fiscal 2019, while the same rose 2.4% in the fiscal fourth quarter mainly due to higher supply-chain and raw material costs. We believe that rising costs and expenses, if unchecked, will be detrimental to the company's margins.

Key Picks

Some better-ranked stocks from the Zacks Industrial Products sector are Albany International Corporation (NYSE:AIN) , AZZ Inc. (NYSE:AZZ) and Dover Corporation (NYSE:DOV) . All these companies carry a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Albany International delivered average positive surprise of 21.27% in the trailing four quarters.

AZZ pulled off average positive surprise of 2.12% in the last four quarters.

Dover came up with average beat of 6.70% in the preceding four quarters.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>-

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


AZZ Inc. (AZZ): Free Stock Analysis Report

Dover Corporation (DOV): Free Stock Analysis Report

Donaldson Company, Inc. (DCI): Free Stock Analysis Report

Albany International Corporation (AIN): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.